Our mission is to confirm or exclude Lynch syndrome. Our innovation simplifies early detection of Lynch syndrome, provides actionable results and can help prevent cancer.
Lynch syndrome (LS) is inherited with 50% probability within affected families. Each single year, more than 2 million new cancer cases should be tested for LS.
Individuals with inherited MMR deficiency have an up to 80% risk of developing cancer and at a significantly younger age than the general population.